全球糖尿病市場(2011年版) 是由出版商Koncept Analytics在2011年10月所出版的。
這份英文市場調查報告書包含58 Pages 價格從美金800起跳。
目前北美和歐洲成為全球最大的糖尿病市場。美國和中國的市場成長位居首位。高齡化的發展和肥胖的增加，都市化的發展伴隨的生活方式的變化(從站著工作轉變為坐著工作的生活)促進糖尿病的蔓延。治療技術方面從動物型胰島素轉為人類胰島素，這次將開發最新型的替代胰島素。
本報告提供全球各國的糖尿病相關市場相關分析，全球性技術·市場趨勢，各地區市場趨勢，最新的市場構向·推動因素·課題，各地區市場競爭環境，再加上主要企業簡介，今後的市場趨勢預測等內容，為您概述為以下內容。
第1章 糖尿病概要
第2章 全球糖尿病市場
- 糖尿病患者的增加
- 治療用各產品的市場
- 主要品牌藥物
- 得病率
- 胰島素市場部門
第3章 糖尿病市場:不同地區的分析
- 美國
- 糖尿病患者的增加
- 市場分析
- 連續血糖市場
- 胰島素市場
- 胰島素幫浦市場
- 主要企業
- 歐洲
- 非洲
- 中東·北非
- 北美·加勒比海地區
- 中南美
- 東南亞
- 西太平洋地區
第4章 市場動態
- 主要趨勢
- 最新型胰島素的人類胰島素的替代
- 新的胰島素設備的開發
- 「坐式生活型態 」(Sedentary Lifestyle)
- 家族病史及遺傳
- 促進成長要素
- 主要的問題
- 充分的診斷·治療的不足
- 糖尿病的成本:對家庭和社會來說的重擔
- 糖尿病的有效的管理
第5章 糖尿病市場:競爭環境
- 全球
- 糖尿病市場市場佔有率
- 胰島素市場市場佔有率
- 胰島素同類產品市場
- 胰島素幫浦的市場佔有率
- 連續血糖監測的市場佔有率
- EU各國
- 中國
- 日本國
第6章 企業簡介
- Novo Nordisk
- 產業概要
- 主要財務指標
- 產業策略
- 改善全球業務
- 革新的開始
- 注重人力資源
- 武田藥品工業
- 產業概要
- 主要財務指標
- 產業策略
- 成長策略的加速
- 全球的徵才·培養
- 全球的品質保證政策
- Sanofi-aventis
- 產業概要
- 主要財務指標
- 產業策略
- 研究開發(R&D)促進策略的增強
- 外部的成長機會
- 未來的課題的應對
- Eli Lilly
- 產業概要
- 主要財務指標
- 產業策略
- 品質保證的提供
- 注重研究和開發活動
第7章 市場預測
- 市場預測
- 預測手法
- 依變數與自變數
- 相關分析
- 迴歸分析
圖表一覽
Abstract
Diabetes is a group of metabolic diseases in which a person has high blood
sugar which is either due to the fact that insulin produced by the body is not
enough or the body does not respond to the insulin that is produced in the
body. Mainly there are three type of diabetes: Type 1 diabetes, Type 2
diabetes and gestational diabetes. Pre-diabetes is a condition that occurs
when blood glucose level of a person is higher than normal but not high enough
so as to diagnose for type 2 diabetes. Depending upon the speed at which the
injected insulin is absorbed by the body, different types of insulin devices
are available in the market. Diabetic population has been continuously
increasing over the years. There are several factors responsible for increase
in diabetic population like family history, obesity, smoking, alcohol,
hypertension, etc.
Just the way human insulin replaced animal insulin, modern insulin is on the
path of replacing human insulin. Ageing population and obesity are among the
key drivers of diabetes market. Due to rising aging population, the
probability of prevalence of chronic disease also increases which is a major
cause of more and more people having diabetes. Urbanization leading to modern
lifestyle also deeply influences the health of the people, thereby increasing
the diabetic population.
Europe has the largest diabetic population and the largest insulin market
followed by North America. Diabetes prevalence rate is high in the US and
China. Novo Nordisk, Takeda, Sanofi-Aventis, Eli Lilly, Merck and GSK are
among the largest players in diabetes market.
The report analyzes the global diabetes market including the US, Europe,
Africa, South and Central America, South and Asia-Pacific. Key issues like
lack of sufficient diagnosis and treatment facilities, cost and effective
management have also been included in this report. The competition prevailing
in the diabetes market has been analyzed with focus on global and regional
market share of major players in diabetes and insulin market. The report also
profiles the major players in the diabetes market.
By combining SPSS Inc.'s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the global diabetic
population. We employed various significant variables that have an impact on
this industry and created regression models with SPSS Base to determine the
future direction of the industry. Before deploying the regression model, the
relationship between several independent or predictor variables and the
dependent variable was analyzed using standard SPSS output, including charts,
tables and tests.
About Koncept Analytics
Overall, Koncept Analytics is a dedicated team, which offers niche reports
that delve in very refined business segment, and also provides high quality
business-to-business and tailored research programmes for each of its clients.
We have seen that many of our clients have utilized our expertise to deliver
ongoing research analysis, be it new product trend analysis, market or
consumer studies.
Table of Contents
1. Introduction to Diabetes Types of Diabetes
2. Global Diabetes Market
- Growth of Diabetic Population
- Market by Treatment Products
- Major Branded Drugs
- Prevalence Rates
- Insulin Market Segments
3. Diabetes Market - Regional Analysis
- 3.1. The US Diabetes Market
- Growth of Diabetic Population
- Market Analysis
- Continuous Glucose Market
- Insulin Market
- Insulin Pump Market
- Major Players
- 3.2. European Diabetes Market
- Diabetes Market
- Regional Breakdown
- Insulin Pump Market
- 3.3. African Diabetes Market
- Market Overview
- Market Size
- 3.4. Middle East/North Africa Diabetes Market
- Market Overview
- Market Size
- 3.5. North America/Caribbean Diabetes Market
- Market Overview
- Market Size
- 3.6. South & Central America Diabetes Market
- Market Overview
- Market Size
- 3.7. South-East Asia Diabetes Market
- Market Overview
- Market Size
- 3.8. Western Pacific Diabetes Market
- Market Overview
- Market Size
4. Market Dynamics
- 4.1. Key Trends
- 4.1.1. Replacement of Human Insulin by Modern Insulin
- 4.1.2. Development of New Insulin Devices
- 4.1.3. Sedentary Lifestyle
- 4.1.4. Family History & Genetics
- 4.2. Growth Drivers
- 4.2.1. Increasing Aging Population
- 4.2.2. Increasing Urbanization
- 4.3. Major Issues
- 4.3.1. Lack of Sufficient Diagnosis & Treatment
- 4.3.2. Diabetes Cost- A Burden for Family & Society
- 4.3.3. Effective Management of Diabetes
5. Diabetes Market - Competitive Landscape
- 5.1. Global
- Diabetes Market Share
- Insulin Market Share
- Insulin Analogues Market
- Insulin Pump Market Share
- Continuous Glucose Monitor Market Share
- 5.2. The EU
- 5.3. China
- 5.4. Japan
6. Company Profiles
- 6.1. Novo Nordisk
- Business Description
- Key Financials
- Business Strategies
- Improving Global Presence
- Undertaking Innovation
- Focus on Human Resources
- 6.2. Takeda
- Business Description
- Key Financials
- Business Strategies
- Accelerating Growth Strategy
- Recruiting & Developing Global Talent
- Global Quality Assurance Policy
- 6.3. Sanofi-aventis
- Business Description
- Key Financials
- Business Strategies
- Increasing R&D Initiatives
- External Growth Opportunities
- Adapting to Future Challenges
- 6.4. Eli Lilly
- Business Description
- Key Financials
- Business Strategies
- Providing Quality Assurance
- Focus on Research & Development
7. Market Outlook
- 7.2. Forecast Methodology
- 7.2.1. Dependent and Independent Variables
- 7.2.2. Correlation Analysis
- 7.2.3. Regression Analysis
List of Charts
- Global Diabetic Population (2004-2010)
- Global Diabetes Population- by Geographical Segments (2010 & 2030E)
- Global Diabetes Market- by Treatment Product (2009)
- Global Diabetes Prevalence Rates (2010)
- Global Insulin Market - by Segments (2010)
- Global Insulin Market - by Geographical Segments (2010)
- No. of New Cases of Diagnosed Diabetes in US (2010E)
- US Continuous Glucose Market (2010)
- US Insulin Market Share (2010)
- US Insulin Pump Market Share (2010 & 2015E)
- Diabetes Patients in Western Europe (2010)
- Insulin Analog- by Types- by Volume (2009)
- Types of Insulin Devices- by Volume (2009)
- Increasing Aging Population over 65 years (2005-2012E)
- Increasing Urban Population (2005-2010)
- Global Diabetes Market Share- by Company (2010)
- Global Total & Modern Insulin Market Share - by Volume (2010)
- Global Insulin Market Share - by Value (2010)
- Global Insulin Analogues Market Share - by Volume (2009)
- Global Continuous Glucose Monitor Market Share (2010E)
- Global Blood Glucose Testing Market Share (2010)
- Global Insulin Pump Market Share (2010)
- Global Insulin Pump Market Share (2009)
- EU Modern Insulin Market Share (2010)
- China Insulin Market Share (2010)
- Japan Insulin Market Share (2010)
- Sales of Novo-Nordisk (2006-2010)
- Sales of Novo-Nordisk- by Business Segments (2010)
- Net Sales of Takeda (2007-2011)
- Net Sales of Takeda- by Business Segments (2011)
- Net Sales of Sanofi-Aventis (2006-2010)
- Net Sales of Sanofi-Aventis- by Business Segments (2010)
- Revenue of Ely Lilly (2006-2010)
- Revenue of Ely Lilly- by Products (2010)
- Revenue of Ely Lilly- by Geographical Segments (2010)
- Global Diabetic Population (2007-2014E)
List of Tables
- Key Branded Diabetes Drugs (2009)
- Global Leading Market Share Position- by Volume (2009)
- Diagnosed & Undiagnosed Diabetes among People in the US (2010)
- Continuous Glucose Market- Home Use Market Opportunity (2010)
- US Diabetes Market Model (2008-2016E)
- US Market for ICU Continuous Glucose Monitoring (2009)
- Continuous Glucose Monitoring Comparison (2010)
- Major Players in the US Diabetes Market
- Key Insulin Pump Devices in Development in the US
- EU Insulin Pump Market (2008-2015E)
- Diabetes Market in Europe (2010E/2030E)
- Diabetes Market in Africa (2010E/2030E)
- Diabetes Market in Middle East and North Africa (2010E/2030E)
- Diabetes Market in North America and Caribbean (2010E/2030E)
- Diabetes Market in South and Central America (2010E/2030E)
- Diabetes Market in South East Asia (2010E/2030E)
- Diabetes Market in Western Pacific (2010E/2030E)
- Dependent & Independent Variables (2005 - 2010)
- Correlation Matrix
- Model Summary - Coefficient of Determination
- Regression Coefficients Output
